Published: 12 November 2022

Committees

Comments on agenda items for the 69th meeting of the Medicines Classification Committee to be held on 25 October 2022

The Medicines Classification Committee and the Secretary wish to thank everyone for their valuable input and feedback.

A total of 34 submissions (PDF, 12MB, 118 pages) commenting on agenda items for the 69th meeting were received. Some of the submissions commented on more than one agenda item. Some parts of the comments have been withheld from publication for reasons described under clause 2b of the Official Information Act 1982.

Agenda Item 5.2 Bilastine

One comment was received about this agenda item.

Agenda Item 6.1a Methenamine hippurate

Four comments were received about this agenda item.

Agenda Item 6.1b Glecaprevir and Pibrentasvir

11 comments were received about this agenda item.

Agenda Item 6.1c Topical and injected local anaesthetics

Two comments were received about this agenda item.

Agenda Item 6.1e National Immunisation Schedule

17 comments were received about this agenda item.

Agenda Item 8.2a Low dose cannabidiol

Five comments were received about this agenda item.